DTx Pharma, a RNA-based therapeutics company, announced that it was one of 3 companies chosen from the JLABs San Diego site to present a 3-minute pitch to a global audience of investors, executives, physicians, strategic investors and government partners located in New York, San Francisco, Boston, Toronto, Houston and San Diego. Following the presentation, DTx was featured in a note and photograph by Arjun Desai, Vice President of Innovation at Johnson & Johnson, “as one of the 20 hottest startups in the world”.